|
1
|
Galluzzi L, Vitale I, Michels J, Brenner
C, Szabadkai G, Harel-Bellan A, Castedo M and Kroemer G: Systems
biology of cisplatin resistance: Past, present and future. Cell
Death Dis. 5:e12572014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warburg O: Iron, the oxygen-carrier of
respiration-ferment. Science. 61:575–582. 1925. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warburg O: On respiratory impairment in
cancer cells. Science. 124:269–270. 1956.PubMed/NCBI
|
|
6
|
Zong WX, Rabinowitz JD and White E:
Mitochondria and cancer. Mol Cell. 61:667–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scarpulla RC: Transcriptional paradigms in
mammalian mitochondrial biogenesis and function. Physiol Rev.
88:611–638. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Neph S, Dinger ME, Crawford J,
Smith MA, Shearwood AM, Haugen E, Bracken CP, Rackham O,
Stamatoyannopoulos JA, et al: The human mitochondrial
transcriptome. Cell. 146:645–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Quirós PM, Mottis A and Auwerx J:
Mitonuclear communication in homeostasis and stress. Nat Rev Mol
Cell Biol. 17:213–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marchetti P, Guerreschi P, Mortier L and
Kluza J: Integration of mitochondrial targeting for molecular
cancer therapeutics. Int J Cell Biol. 2015:2831452015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y and Xu H: Translational regulation
of mitochondrial biogenesis. Biochem Soc Trans. 44:1717–1724. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fernandez-Marcos PJ and Auwerx J:
Regulation of PGC-1α, a nodal regulator of mitochondrial
biogenesis. Am J Clin Nutr. 93:884S–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan Z, Luo X, Xiao L, Tang M, Bode AM,
Dong Z and Cao Y: The role of PGC1α in cancer metabolism and its
therapeutic implications. Mol Cancer Ther. 15:774–782. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Permuth-Wey J, Chen YA, Tsai YY, Chen Z,
Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, et
al: Inherited variants in mitochondrial biogenesis genes may
influence epithelial ovarian cancer risk. Cancer Epidemiol
Biomarkers Prev. 20:1131–1145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haq R, Shoag J, Andreu-Perez P, Yokoyama
S, Edelman H, Rowe GC, Frederick DT, Hurley AD, Nellore A, Kung AL,
et al: Oncogenic BRAF regulates oxidative metabolism via PGC1α and
MITF. Cancer Cell. 23:302–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gopal YN, Rizos H, Chen G, Deng W,
Frederick DT, Cooper ZA, Scolyer RA, Pupo G, Komurov K, Sehgal V,
et al: Inhibition of mTORC1/2 overcomes resistance to MAPK pathway
inhibitors mediated by PGC1α and oxidative phosphorylation in
melanoma. Cancer Res. 74:7037–7047. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Z, Puigserver P, Andersson U, Zhang C,
Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, et
al: Mechanisms controlling mitochondrial biogenesis and respiration
through the thermogenic coactivator PGC-1. Cell. 98:115–124. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Puigserver P and Spiegelman BM: Peroxisome
proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1
alpha): Transcriptional coactivator and metabolic regulator. Endocr
Rev. 24:78–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gleyzer N, Vercauteren K and Scarpulla RC:
Control of mitochondrial transcription specificity factors (TFB1M
and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and
PGC-1 family coactivators. Mol Cell Biol. 25:1354–1366. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scarpulla RC: Nuclear control of
respiratory chain expression by nuclear respiratory factors and
PGC-1-related coactivator. Ann N Y Acad Sci. 1147:321–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vellinga TT, Borovski T, de Boer VC,
Fatrai S, van Schelven S, Trumpi K, Verheem A, Snoeren N, Emmink
BL, Koster J, et al: SIRT1/PGC1α-dependent increase in oxidative
phosphorylation supports chemotherapy resistance of colon cancer.
Clin Cancer Res. 21:2870–2879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao W, Wu MH, Wang N, Ying MZ, Zhang YY,
Hua J, Chuan L and Wang YJ: Mitochondrial transcription factor A
contributes to cisplatin resistance in patients with estrogen
receptor-positive breast cancer. Mol Med Rep. 14:5304–5310. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel
W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L, et al:
PGC1α promotes tumor growth by inducing gene expression programs
supporting lipogenesis. Cancer Res. 71:6888–6898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vazquez F, Lim JH, Chim H, Bhalla K,
Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman
BM, et al: PGC1α expression defines a subset of human melanoma
tumors with increased mitochondrial capacity and resistance to
oxidative stress. Cancer Cell. 23:287–301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Do MT, Kim HG, Choi JH and Jeong HG:
Metformin induces microRNA-34a to downregulate the
Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of
wild-type p53 cancer cells to oxidative stress and therapeutic
agents. Free Radic Biol Med. 74:21–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jones AW, Yao Z, Vicencio JM,
Karkucinska-Wieckowska A and Szabadkai G: PGC-1 family coactivators
and cell fate: Roles in cancer, neurodegeneration, cardiovascular
disease and retrograde mitochondria-nucleus signalling.
Mitochondrion. 12:86–99. 2012. View Article : Google Scholar
|
|
27
|
Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo
J and Hu X: Shikonin circumvents cancer drug resistance by
induction of a necroptotic death. Mol Cancer Ther. 6:1641–1649.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Eaton JS, Lin ZP, Sartorelli AC, Bonawitz
ND and Shadel GS: Ataxia-telangiectasia mutated kinase regulates
ribonucleotide reductase and mitochondrial homeostasis. J Clin
Invest. 117:2723–2734. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lebedeva MA, Eaton JS and Shadel GS: Loss
of p53 causes mitochondrial DNA depletion and altered mitochondrial
reactive oxygen species homeostasis. Biochim Biophys Acta.
1787:328–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu H, Su J, Xu Y, Kang J, Li H, Zhang L,
Yi H, Xiang X, Liu F and Sun L: p62/SQSTM1 involved in cisplatin
resistance in human ovarian cancer cells by clearing ubiquitinated
proteins. Eur J Cancer. 47:1585–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Medeiros DM: Assessing mitochondria
biogenesis. Methods. 46:288–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma L, Xu Y, Su J, Yu H, Kang J, Li H, Li
X, Xie Q, Yu C, Sun L, et al: Autophagic flux promotes cisplatin
resistance in human ovarian carcinoma cells through ATP-mediated
lysosomal function. Int J Oncol. 47:1890–1900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Agarwal R and Kaye SB: Ovarian cancer:
Strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schulze A and Harris AL: How cancer
metabolism is tuned for proliferation and vulnerable to disruption.
Nature. 491:364–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pan Y, Cao M, Liu J, Yang Q, Miao X, Go
VLW, Lee PWN and Xiao GG: Metabolic regulation in mitochondria and
drug resistance. Adv Exp Med Biol. 1038:149–171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shao D, Liu Y, Liu X, Zhu L, Cui Y, Cui A,
Qiao A, Kong X, Liu Y, Chen Q, et al: PGC-1 beta-regulated
mitochondrial biogenesis and function in myotubes is mediated by
NRF-1 and ERR alpha. Mitochondrion. 10:516–527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
LaGory EL, Wu C, Taniguchi CM, Ding CC,
Chi JT, von Eyben R, Scott DA, Richardson AD and Giaccia AJ:
Suppression of PGC-1α is critical for reprogramming oxidative
metabolism in renal cell carcinoma. Cell Reports. 12:116–127. 2015.
View Article : Google Scholar
|
|
39
|
Cam H, Balciunaite E, Blais A, Spektor A,
Scarpulla RC, Young R, Kluger Y and Dynlacht BD: A common set of
gene regulatory networks links metabolism and growth inhibition.
Mol Cell. 16:399–411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kelly DP and Scarpulla RC: Transcriptional
regulatory circuits controlling mitochondrial biogenesis and
function. Genes Dev. 18:357–368. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Scarpulla RC: Nuclear activators and
coactivators in mammalian mitochondrial biogenesis. Biochim Biophys
Acta. 1576:1–14. 2002. View Article : Google Scholar
|
|
42
|
Scarpulla RC: Metabolic control of
mitochondrial biogenesis through the PGC-1 family regulatory
network. Biochim Biophys Acta. 1813:1269–1278. 2011. View Article : Google Scholar :
|
|
43
|
Mootha VK, Handschin C, Arlow D, Xie X, St
Pierre J , Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N,
et al: Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative
phosphorylation gene expression that is altered in diabetic muscle.
Proc Natl Acad Sci USA. 101:6570–6575. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Girnun GD: The diverse role of the PPARγ
coactivator 1 family of transcriptional coactivators in cancer.
Semin Cell Dev Biol. 23:381–388. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jain A, Bakhshi S, Thakkar H, Gerards M
and Singh A: Elevated mitochondrial DNA copy numbers in pediatric
acute lymphoblastic leukemia: A potential biomarker for predicting
inferior survival. Pediatr Blood Cancer. Nov 14–2017.Epub ahead of
print. PubMed/NCBI
|
|
46
|
Wang Y, He S, Zhu X, Qiao W and Zhang J:
High copy number of mitochondrial DNA predicts poor prognosis in
patients with advanced stage colon cancer. Int J Biol Markers.
31:e382–e388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang G, Qu Y, Dang S, Yang Q, Shi B and
Hou P: Variable copy number of mitochondrial DNA (mtDNA) predicts
worse prognosis in advanced gastric cancer patients. Diagn Pathol.
8:1732013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hatok J and Racay P: Bcl-2 family
proteins: Master regulators of cell survival. Biomol Concepts.
7:259–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zaltsman Y, Shachnai L, Yivgi-Ohana N,
Schwarz M, Maryanovich M, Houtkooper RH, Vaz FM, De Leonardis F,
Fiermonte G, Palmieri F, et al: MTCH2/MIMP is a major facilitator
of tBID recruitment to mitochondria. Nat Cell Biol. 12:553–562.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Milane L, Trivedi M, Singh A, Talekar M
and Amiji M: Mitochondrial biology, targets, and drug delivery. J
Control Release. 207:40–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
